Your browser doesn't support javascript.
loading
Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Gupta, Rohan; Cristea, Mihaela; Frankel, Paul; Ruel, Christopher; Chen, Chen; Wang, Yingyu; Morgan, Robert; Leong, Lucille; Chow, Warren; Koczywas, Marianna; Koehler, Steve; Lim, Dean; Luu, Thehang; Martel, Cynthia; McNamara, Mark; Somlo, George; Twardowski, Przemyslaw; Yen, Yun; Idorenyi, Amanam; Raechelle, Tinsley; Carroll, Mary; Chung, Vincent.
Affiliation
  • Gupta R; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Cristea M; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Frankel P; Information Sciences, City of Hope National Cancer Center, Duarte, CA, United States.
  • Ruel C; Information Sciences, City of Hope National Cancer Center, Duarte, CA, United States.
  • Chen C; Clinical Informatics, City of Hope National Cancer Center, Duarte, CA, United States.
  • Wang Y; Clinical Informatics, City of Hope National Cancer Center, Duarte, CA, United States.
  • Morgan R; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Leong L; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Chow W; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Koczywas M; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Koehler S; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Lim D; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Luu T; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Martel C; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • McNamara M; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Somlo G; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Twardowski P; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Yen Y; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Idorenyi A; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States.
  • Raechelle T; Clinical Trial Office, City of Hope National Cancer Center, Duarte, CA, United States.
  • Carroll M; Clinical Trial Office, City of Hope National Cancer Center, Duarte, CA, United States.
  • Chung V; Department of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, CA, United States. Electronic address: VChung@coh.org.
Cancer Treat Res Commun ; 21: 100155, 2019.
Article in En | MEDLINE | ID: mdl-31279962

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents, Alkylating / Angiogenesis Inhibitors / Cyclophosphamide / Fallopian Tube Neoplasms / Celecoxib / Carcinoma, Ovarian Epithelial Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Cancer Treat Res Commun Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents, Alkylating / Angiogenesis Inhibitors / Cyclophosphamide / Fallopian Tube Neoplasms / Celecoxib / Carcinoma, Ovarian Epithelial Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Cancer Treat Res Commun Year: 2019 Document type: Article Affiliation country: